Esteban C., Perez P., Fernández-Llamazares J. , et al. Clinical outcome in patients with peripheral artery disease and renal artery stenosis. Angiology.2010;61(1):58-65.
2.
Paraskevas KI , Giannoukas AD, Mikhailidis DPRenal function impairment in peripheral arterial disease: an important parameter that should not be neglected. Ann Vasc Surg.2009; 23(5):690-699.
3.
O’Hare AM, Bertenthal D., Schlipak MG, Sen S., Chren MMImpact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol. 2005; 16(2):514-519.
4.
Owens CD, Ho KJ, Kim S., et al. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification . J Vasc Surg. 2007;45(5):944-952.
5.
Alnaeb ME, Alobaid N., Seifalian AM, Mikhailidis DP, Hamilton G.Statins and peripheral arterial disease: potential mechanisms and clinical benefits. Ann Vasc Surg. 2006;20(5): 696-705.
6.
Youssef F., Gupta P., Seifalian AM, Myint F., Mikhailidis DP, Hamilton G.The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease. Angiology. 2004;55(1):53-62.
7.
Paraskevas KI , Liapis CD, Hamilton G., Mikhailidis DPCan statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery? Eur J Vasc Endovasc Surg. 2006;32(3):286-293.
8.
Paraskevas KI , Athyros VG, Briana DD, Kakafika AI, Karagiannis A., Mikhailidis DPStatins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets. 2007;8(8):942-951.
